Pathology: Page 65

Gene mutation plays role in head and neck cancer
By DrBicuspid.com staff writers
Researchers from several major U.S. biomedical centers recently collaborated to shine a light on head and neck squamous cell cancer. Their large-scale analyses, published in Science, reveal a surprising new set of mutations involved in this disease.
July 28, 2011
2011 03 21 11 32 57 244 Salivary Glands 70
Study finds no link between fluoride and osteosarcoma
By Kathy Kincade
There is no significant association between bone fluoride levels and osteosarcoma risk, according to a new case-control study in the Journal of Dental Research. Fluoridation proponents say this should put to rest any fears of a correlation between fluoride and cancer.
July 27, 2011
2008 11 10 11 04 21 112 Fluoride 70
Military health plan adds oral mucositis product
By DrBicuspid.com staff writers
MuGard, a novel treatment for oral mucositis developed by Access Pharmaceuticals, is now being covered by Tricare, the U.S. military health plan.
July 26, 2011
U.K. researchers study novel esophageal cancer test
By DrBicuspid.com staff writers
Cancer Research U.K. has launched a large, multicenter trial to test a new device for detecting Barrett's esophagus, a condition that puts sufferers at increased risk of developing cancer of the esophagus.
July 26, 2011
LED Dental adds camera to VELscope Vx
By DrBicuspid.com staff writers
LED Dental has released a camera system to complement VELscope Vx, designed to help detect and document abnormal mucosal tissue.
July 26, 2011
Cancer screening clinics help reduce tobacco use
By DrBicuspid.com staff writers
Participating in a community-based head and neck cancer screening clinic can help reduce tobacco use in at-risk populations, according to a study published online July 21 in Otolaryngology -- Head and Neck Surgery.
July 24, 2011
Oral bisphosphonates may up risk of esophageal cancer
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration is continuing to review data from published studies to evaluate whether the use of oral bisphosphonates is associated with an increased risk of esophageal cancer.
July 20, 2011
2009 07 28 13 33 39 581 Fda Logo 70
CEL-SCI licenses head/neck cancer drug for Croatia, Serbia
By DrBicuspid.com staff writers
CEL-SCI has expanded its licensing agreement with Teva Pharmaceutical Industries for its cancer drug Multikine, CEL-SCI's investigational phase III drug for the treatment of head and neck cancer.
July 19, 2011
Nanoparticles attack head/neck cancer
By DrBicuspid.com staff writers
Using tumor-targeted nanoparticles to deliver high doses of anticancer agents directly to head and neck tumors increases survival while triggering fewer side effects, according to a study in the Journal of Oral and Maxillofacial Surgery.
July 17, 2011
Clinical trial to test new head/neck cancer drug
By DrBicuspid.com staff writers
The U.S. Food and Drug Administration has approved a national clinical trial to study the safety and effectiveness of a drug treatment on patients receiving radiation and chemotherapy for head and neck cancer.
July 14, 2011
OralCDx aids in monitoring leukoplakia
By DrBicuspid.com staff writers
The OralCDx brush test demonstrated high sensitivity and specificity values in diagnosing and monitoring oral leukoplakia, according to a study in Oral Medicine, Oral Pathology and Oral Surgery.
July 14, 2011
Proper denture fit could help prevent dementia
By DrBicuspid.com staff writers
Improving and maintaining health factors not traditionally associated with dementia, such as denture fit, vision, and hearing, may lower a person's risk for developing dementia, according to a new study.
July 13, 2011
Previous Page
Page 65 of 87
Next Page